Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Additional registration fee required

Faculty have requested this content not be shared on social media

CME Credit Offered

Poster Icons

Foundation Awardee

No Social Media

Back

Q&A

Clinical Obstetrics

Poster Session 1

(347) Hyperemesis Gravidarum: Investigating Pregnancy Outcomes by Severity and Time of Diagnosis

Tuesday, February 13, 2024

10:30 AM – 12:00 PM

Location: Prince George's Exhibit Hall CDE, Lower Atrium Level

Primary Author(s)

Omri Porgador, BSc

Joyce & Irving Goldman Medical School, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel.
Lehavim, HaDarom, Israel

Coauthor(s)

Eyal Sheiner, MD, PhD

Head of department of Obstetrics and Gynecology B, Soroka University Medical Center
Soroka University Medical Center
Beer-Sheva, HaDarom, Israel
Gali Pariente, MD

Acting director of Fetal Maternal Unit B Division of Obstetrics and Gynecology
Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel
Klahim, HaDarom, Israel

Presenting Author(s)

Tamar Wainstock, PhD (she/her/hers)

Ben Gurion University
Beer-Sheva, HaDarom, Israel

Objective: With inconsistencies regarding the possible effect of hyperemesis gravidarum on the course of pregnancy, this research aimed to study the association between hyperemesis gravidarum and pregnancy outcomes, while addressing the trimester of diagnosis and severity of the disease.

Study Design: A population-based retrospective cohort study was conducted, including all singleton deliveries of mothers from the largest health maintenance organization in the country, in a single tertiary hospital between the years 1991-2021. Incidence of adverse pregnancy outcomes was compared between pregnancies with and without hyperemesis gravidarum diagnosis, including preterm birth, low birth weight, cesarean delivery, and perinatal mortality. Severe cases were defined as hyperemesis gravidarum with metabolic disturbances. Multivariable Generalized Estimation Equation binary models were used to study the association between maternal hyperemesis gravidarum, trimester of diagnosis and severity, and the studied outcomes while adjusting for smoking, nulliparity, fertility treatments, ethnicity, gender, maternal age, and maternal recurrence in the cohort.

Results: The study population included 232,476 pregnancies, of which 3227 (1.4%) were complicated with hyperemesis gravidarum. Women with hyperemesis gravidarum were more likely to deliver preterm (adjusted OR=1.30, 95%CI 1.14-1.47), a newborn with low birth weight (adj. OR=1.52, 95%CI 1.16-1.98, only if diagnosed in the second trimester), and to have a cesarean delivery (adj. OR=1.22, 95%CI 1.10-1.35). They were less likely to experience perinatal mortality (adj. OR=0.54, 95%CI 0.31-0.93, among mild cases only). A dose-response association was observed between preterm birth and hyperemesis gravidarum severity (Table).

Conclusion: Hyperemesis gravidarum is associated with an increased risk for preterm birth, low birth weight, and cesarean delivery, specifically among women diagnosed during the second trimester. However, it is associated with a lower risk for perinatal mortality.